Millennium Management’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,824
Closed -$211K 6244
2025
Q4
$211K Buy
+26,824
New +$172K ﹤0.01% 5448
2025
Q2
Sell
-12,758
Closed -$74.2K 6236
2025
Q1
$74.2K Buy
+12,758
New +$88.1K ﹤0.01% 5486
2024
Q4
Sell
-53,633
Closed -$427K 6357
2024
Q3
$427K Buy
+53,633
New +$485K ﹤0.01% 4951
2021
Q4
Sell
-29,107
Closed -$426K 7260
2021
Q3
$426K Buy
+29,107
New +$443K ﹤0.01% 5494
2021
Q2
Sell
-21,606
Closed -$435K 6986
2021
Q1
$435K Sell
21,606
-1,953
-8% -$46.8K ﹤0.01% 4935
2020
Q4
$484K Sell
23,559
-16,511
-41% -$304K ﹤0.01% 4224
2020
Q3
$707 Buy
40,070
+26,494
+195% +$421K ﹤0.01% 3373
2020
Q2
$230K Sell
13,576
-15,624
-54% -$197K ﹤0.01% 3783
2020
Q1
$284K Buy
+29,200
New +$379K ﹤0.01% 3205

Other funds holding PROF

Millennium Management's PROF Position: Q1 2026 in Review

Millennium Management sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 26,824 shares — an estimated $211K sold.

Millennium Management first reported a position in PROF in Q1 2020 and held it in 9 quarters. The position peaked at $484K in Q4 2020. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Millennium Management reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 26,824 Profound Medical shares in Q1 2026, an estimated $211K.
  • Millennium Management first reported a position in Profound Medical in Q1 2020 and held it in 9 quarters.
  • Millennium Management's Profound Medical position peaked at $484K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.